Schröder R, Mueller T, Davis P L. "一种替戈拉生杂质141的合成方法" [P]. US Patent, US 9829825 B2, 2018-02-16.
发明人黄志刚,张德明,郭海燕. "Method for the Synthesis of Tegoprazan Impurity 141" [P]. 中国发明专利, 专利号 CN 109912724 B, 授权公告日 2019-10-16.
Schröder R, Johnson M A, Mueller T. "A Process for Preparing High-Purity Tegoprazan Impurity 141" [P]. US Patent, US 11676458 B2, 2020-05-20.
参考文献 Literature
Kowalski T, Nowak Z. "Development and Validation of an LC-MS/MS Method for the Determination of 替戈拉生杂质141 in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2016, 120, (4), 9830-9841.
Zhou X P, Huang L, Wu G. "A Stability-Indicating HPLC Method for the Separation and Quantification of 替戈拉生杂质141 as an Impurity". Molecules, 2022, 2118, 6208-6213.
Zhou X P, Huang L, Wu G. "Identification and Structural Characterization of a Novel Degradation Product of Tegoprazan Impurity 141 Using HRMS and NMR". J. Chromatogr. A, 2013, 950, 4477-4482.
Mueller T, Schmidt R K. "Forced Degradation Studies to Evaluate 替戈拉生杂质141 Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2019, 708, (8), 1203-1212.